Loading…
Reported covered position: SENIOR DIRECTOR, GOVERNMENT RELATIONS
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
FDA reform proposals; Pseudoephedrine H.R. 1259 DXM Distribution Act Monograph System Reform Proposal Pseudoephedrine Electronic Log Proposal
FDA reform proposals; Pseudoephedrine H.R. 1259 DXM Distribution Act Monograph System Reform Proposal Pseudoephedrine Electronic Log Proposal S.1383 Dextromethorphan Abuse Reduction Act of 2009 H.R. 2749 Food Safety Enhancement Act of 2009 S. 510 Food Safety Modernization Act of 2009
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
S. 726/H.R. 1427 - Access to Life-Saving Medicine Act, Follow-on Biologics H.R. 1548 - The Pathway for Biosimilars Act Biosimilars Drug Safety Prescription Drug Importation Import Safety Compounding H.R. 759 - Food and Drug Administration Globaliation Act of 2009 S. 510 - FDA Food Safety Modernization Act
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Chronic care out of pocket costs Medicare Prescription Drug Benefit Medicaid drug rebate Medicare and Medicaid Drug Reimbursement Medicaid Part D Non-Interference S.301/HR 3138 Physician Payments Sunshine Act of 2009 S.547/H.R. 904 - Drug Rebate Equalization Act of 2009 H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009 S.266 - Medicare Prescription Drug Gap Reduction Act of 2009 S.1679 Affordable Health Choices Act
Source: Senate LDA
FDA reform proposals; Pseudoephedrine H.R. 1259 DXM Distribution Act Monograph System Reform Proposal Pseudoephedrine Electronic Log Proposal S.1383 Dextromethorphan Abuse Reduction Act of 2009 H.R. 2749 Food Safety Enhancement Act of 2009 S. 510 Food Safety Modernization Act of 2009
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Hormone replacement therapies Chronic care out of pocket costs Federal preemption Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to bioidentical hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 Federal preemption for prescription drugs
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care reform legislation FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S.1679 Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S. ___ Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Hormone replacement therapies Chronic care out of pocket costs Federal preemption Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to bioidentical hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 Federal preemption for prescription drugs
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care reform legislation FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S.1679 Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S. ___ Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
S. 726/H.R. 1427 - Access to Life-Saving Medicine Act, Follow-on Biologics H.R. 1548 - The Pathway for Biosimilars Act Biosimilars Drug Safety Prescription Drug Importation Import Safety Compounding H.R. 759 - Food and Drug Administration Globaliation Act of 2009 S. 510 - FDA Food Safety Modernization Act
S. 726/H.R. 1427 - Access to Life-Saving Medicine Act, Follow-on Biologics H.R. 1548 - The Pathway for Biosimilars Act Biosimilars Drug Safety Prescription Drug Importation Import Safety Compounding H.R. 759 - Food and Drug Administration Globaliation Act of 2009 S. 510 - FDA Food Safety Modernization Act
S. 726/H.R. 1427 - Access to Life-Saving Medicine Act, Follow-on Biologics H.R. 1548 - The Pathway for Biosimilars Act Biosimilars Drug Safety Prescription Drug Importation Import Safety Compounding H.R. 759 - Food and Drug Administration Globaliation Act of 2009 S. 510 - FDA Food Safety Modernization Act
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S. ___ Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
S. 726/H.R. 1427 - Access to Life-Saving Medicine Act, Follow-on Biologics H.R. 1548 - The Pathway for Biosimilars Act Biosimilars Drug Safety Prescription Drug Importation Import Safety Compounding H.R. 759 - Food and Drug Administration Globaliation Act of 2009 S. 510 - FDA Food Safety Modernization Act
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care reform legislation FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S.1679 Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
S. 726/H.R. 1427 - Access to Life-Saving Medicine Act, Follow-on Biologics H.R. 1548 - The Pathway for Biosimilars Act Biosimilars Drug Safety Prescription Drug Importation Import Safety Compounding H.R. 759 - Food and Drug Administration Globaliation Act of 2009 S. 510 - FDA Food Safety Modernization Act
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Hormone replacement therapies Chronic care out of pocket costs Federal preemption Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to bioidentical hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 Federal preemption for prescription drugs
S. 726/H.R. 1427 - Access to Life-Saving Medicine Act, Follow-on Biologics H.R. 1548 - The Pathway for Biosimilars Act Biosimilars Drug Safety Prescription Drug Importation Import Safety Compounding H.R. 759 - Food and Drug Administration Globaliation Act of 2009 S. 510 - FDA Food Safety Modernization Act
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Hormone replacement therapies Chronic care out of pocket costs Federal preemption Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to bioidentical hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 Federal preemption for prescription drugs
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care reform legislation FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S.1679 Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S. ___ Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Chronic care out of pocket costs Medicare Prescription Drug Benefit Medicaid drug rebate Medicare and Medicaid Drug Reimbursement Medicaid Part D Non-Interference S.301/HR 3138 Physician Payments Sunshine Act of 2009 S.547/H.R. 904 - Drug Rebate Equalization Act of 2009 H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009 S.266 - Medicare Prescription Drug Gap Reduction Act of 2009 S.1679 Affordable Health Choices Act
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Chronic care out of pocket costs Medicare Prescription Drug Benefit Medicaid drug rebate Medicare and Medicaid Drug Reimbursement Medicaid Rebate Medicaid Part D Non-Interference S.301 Physician Payments Sunshine Act of 2009 S.547/H.R. 904 - Drug Rebate Equalization Act of 2009 H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009 S.266 - Medicare Prescription Drug Gap Reduction Act of 2009
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Chronic care out of pocket costs Medicare Prescription Drug Benefit Medicaid drug rebate Medicare and Medicaid Drug Reimbursement Medicaid Part D Non-Interference S.301 Physician Payments Sunshine Act of 2009 S.547/H.R. 904 - Drug Rebate Equalization Act of 2009 H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009 S.266 - Medicare Prescription Drug Gap Reduction Act of 2009 H.R. ____ - House Tri-Committee Health Reform S.____ Affordable Health Choices Act
FDA reform proposals; Pseudoephedrine H.R. 1259 DXM Distribution Act Monograph System Reform Proposal Pseudoephedrine Electronic Log Proposal S.1383 Dextromethorphan Abuse Reduction Act of 2009 H.R. 2749 Food Safety Enhancement Act of 2009 S. 510 Food Safety Modernization Act of 2009
FDA reform proposals; Pseudoephedrine H.R. 1259 DXM Distribution Act Monograph System Reform Proposal Pseudoephedrine Electronic Log Proposal S.1383 Dextromethorphan Abuse Reduction Act of 2009 H.R. 2749 Food Safety Enhancement Act of 2009 S. 510 Food Safety Modernization Act of 2009
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Chronic care out of pocket costs Medicare Prescription Drug Benefit Medicaid drug rebate Medicare and Medicaid Drug Reimbursement Medicaid Part D Non-Interference S.301/HR 3138 Physician Payments Sunshine Act of 2009 S.547/H.R. 904 - Drug Rebate Equalization Act of 2009 H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009 S.266 - Medicare Prescription Drug Gap Reduction Act of 2009 S.1679 Affordable Health Choices Act
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S. ___ Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care reform legislation FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S.1679 Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S. ___ Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Hormone replacement therapies Chronic care out of pocket costs Federal preemption Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to bioidentical hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 Federal preemption for prescription drugs
To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care reform legislation FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S.1679 Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Hormone replacement therapies Chronic care out of pocket costs Federal preemption Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to bioidentical hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 Federal preemption for prescription drugs
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S. ___ Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care reform legislation FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S.1679 Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Chronic care out of pocket costs Medicare Prescription Drug Benefit Medicaid drug rebate Medicare and Medicaid Drug Reimbursement Medicaid Rebate Medicaid Part D Non-Interference S.301 Physician Payments Sunshine Act of 2009 S.547/H.R. 904 - Drug Rebate Equalization Act of 2009 H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009 S.266 - Medicare Prescription Drug Gap Reduction Act of 2009
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Chronic care out of pocket costs Medicare Prescription Drug Benefit Medicaid drug rebate Medicare and Medicaid Drug Reimbursement Medicaid Part D Non-Interference S.301/HR 3138 Physician Payments Sunshine Act of 2009 S.547/H.R. 904 - Drug Rebate Equalization Act of 2009 H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009 S.266 - Medicare Prescription Drug Gap Reduction Act of 2009 S.1679 Affordable Health Choices Act
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Chronic care out of pocket costs Medicare Prescription Drug Benefit Medicaid drug rebate Medicare and Medicaid Drug Reimbursement Medicaid Part D Non-Interference S.301 Physician Payments Sunshine Act of 2009 S.547/H.R. 904 - Drug Rebate Equalization Act of 2009 H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009 S.266 - Medicare Prescription Drug Gap Reduction Act of 2009 H.R. ____ - House Tri-Committee Health Reform S.____ Affordable Health Choices Act
S. 726/H.R. 1427 - Access to Life-Saving Medicine Act, Follow-on Biologics H.R. 1548 - The Pathway for Biosimilars Act Biosimilars Drug Safety Prescription Drug Importation Import Safety Compounding H.R. 759 - Food and Drug Administration Globaliation Act of 2009 S. 510 - FDA Food Safety Modernization Act
S. 726/H.R. 1427 - Access to Life-Saving Medicine Act, Follow-on Biologics H.R. 1548 - The Pathway for Biosimilars Act Biosimilars Drug Safety Prescription Drug Importation Import Safety Compounding H.R. 759 - Food and Drug Administration Globaliation Act of 2009 S. 510 - FDA Food Safety Modernization Act
S. 726/H.R. 1427 - Access to Life-Saving Medicine Act, Follow-on Biologics H.R. 1548 - The Pathway for Biosimilars Act Biosimilars Drug Safety Prescription Drug Importation Import Safety Compounding H.R. 759 - Food and Drug Administration Globaliation Act of 2009 S. 510 - FDA Food Safety Modernization Act
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Chronic care out of pocket costs Medicare Prescription Drug Benefit Medicaid drug rebate Medicare and Medicaid Drug Reimbursement Medicaid Part D Non-Interference S.301 Physician Payments Sunshine Act of 2009 S.547/H.R. 904 - Drug Rebate Equalization Act of 2009 H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009 S.266 - Medicare Prescription Drug Gap Reduction Act of 2009 H.R. ____ - House Tri-Committee Health Reform S.____ Affordable Health Choices Act
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Chronic care out of pocket costs Medicare Prescription Drug Benefit Medicaid drug rebate Medicare and Medicaid Drug Reimbursement Medicaid Part D Non-Interference S.301/HR 3138 Physician Payments Sunshine Act of 2009 S.547/H.R. 904 - Drug Rebate Equalization Act of 2009 H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009 S.266 - Medicare Prescription Drug Gap Reduction Act of 2009 S.1679 Affordable Health Choices Act
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Chronic care out of pocket costs Medicare Prescription Drug Benefit Medicaid drug rebate Medicare and Medicaid Drug Reimbursement Medicaid Rebate Medicaid Part D Non-Interference S.301 Physician Payments Sunshine Act of 2009 S.547/H.R. 904 - Drug Rebate Equalization Act of 2009 H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009 S.266 - Medicare Prescription Drug Gap Reduction Act of 2009
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S. ___ Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care reform legislation FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S.1679 Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
FDA reform proposals; Pseudoephedrine H.R. 1259 DXM Distribution Act Monograph System Reform Proposal Pseudoephedrine Electronic Log Proposal S.1383 Dextromethorphan Abuse Reduction Act of 2009 H.R. 2749 Food Safety Enhancement Act of 2009 S. 510 Food Safety Modernization Act of 2009
FDA reform proposals; Pseudoephedrine H.R. 1259 DXM Distribution Act Monograph System Reform Proposal Pseudoephedrine Electronic Log Proposal S.1383 Dextromethorphan Abuse Reduction Act of 2009 H.R. 2749 Food Safety Enhancement Act of 2009 S. 510 Food Safety Modernization Act of 2009
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Chronic care out of pocket costs Medicare Prescription Drug Benefit Medicaid drug rebate Medicare and Medicaid Drug Reimbursement Medicaid Part D Non-Interference S.301/HR 3138 Physician Payments Sunshine Act of 2009 S.547/H.R. 904 - Drug Rebate Equalization Act of 2009 H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009 S.266 - Medicare Prescription Drug Gap Reduction Act of 2009 S.1679 Affordable Health Choices Act
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care reform legislation FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S.1679 Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Chronic care out of pocket costs Medicare Prescription Drug Benefit Medicaid drug rebate Medicare and Medicaid Drug Reimbursement Medicaid Part D Non-Interference S.301/HR 3138 Physician Payments Sunshine Act of 2009 S.547/H.R. 904 - Drug Rebate Equalization Act of 2009 H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009 S.266 - Medicare Prescription Drug Gap Reduction Act of 2009 S.1679 Affordable Health Choices Act
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Chronic care out of pocket costs Medicare Prescription Drug Benefit Medicaid drug rebate Medicare and Medicaid Drug Reimbursement Medicaid Part D Non-Interference S.301 Physician Payments Sunshine Act of 2009 S.547/H.R. 904 - Drug Rebate Equalization Act of 2009 H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009 S.266 - Medicare Prescription Drug Gap Reduction Act of 2009 H.R. ____ - House Tri-Committee Health Reform S.____ Affordable Health Choices Act
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Chronic care out of pocket costs Medicare Prescription Drug Benefit Medicaid drug rebate Medicare and Medicaid Drug Reimbursement Medicaid Rebate Medicaid Part D Non-Interference S.301 Physician Payments Sunshine Act of 2009 S.547/H.R. 904 - Drug Rebate Equalization Act of 2009 H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009 S.266 - Medicare Prescription Drug Gap Reduction Act of 2009
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Hormone replacement therapies Chronic care out of pocket costs Federal preemption Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to bioidentical hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 Federal preemption for prescription drugs
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S. ___ Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Chronic care out of pocket costs Medicare Prescription Drug Benefit Medicaid drug rebate Medicare and Medicaid Drug Reimbursement Medicaid Part D Non-Interference S.301/HR 3138 Physician Payments Sunshine Act of 2009 S.547/H.R. 904 - Drug Rebate Equalization Act of 2009 H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009 S.266 - Medicare Prescription Drug Gap Reduction Act of 2009 S.1679 Affordable Health Choices Act
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care reform legislation FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S.1679 Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Chronic care out of pocket costs Medicare Prescription Drug Benefit Medicaid drug rebate Medicare and Medicaid Drug Reimbursement Medicaid Part D Non-Interference S.301 Physician Payments Sunshine Act of 2009 S.547/H.R. 904 - Drug Rebate Equalization Act of 2009 H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009 S.266 - Medicare Prescription Drug Gap Reduction Act of 2009 H.R. ____ - House Tri-Committee Health Reform S.____ Affordable Health Choices Act
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Chronic care out of pocket costs Medicare Prescription Drug Benefit Medicaid drug rebate Medicare and Medicaid Drug Reimbursement Medicaid Rebate Medicaid Part D Non-Interference S.301 Physician Payments Sunshine Act of 2009 S.547/H.R. 904 - Drug Rebate Equalization Act of 2009 H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009 S.266 - Medicare Prescription Drug Gap Reduction Act of 2009
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Chronic care out of pocket costs Medicare Prescription Drug Benefit Medicaid drug rebate Medicare and Medicaid Drug Reimbursement Medicaid Part D Non-Interference S.301/HR 3138 Physician Payments Sunshine Act of 2009 S.547/H.R. 904 - Drug Rebate Equalization Act of 2009 H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009 S.266 - Medicare Prescription Drug Gap Reduction Act of 2009 S.1679 Affordable Health Choices Act
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Chronic care out of pocket costs Medicare Prescription Drug Benefit Medicaid drug rebate Medicare and Medicaid Drug Reimbursement Medicaid Part D Non-Interference S.301 Physician Payments Sunshine Act of 2009 S.547/H.R. 904 - Drug Rebate Equalization Act of 2009 H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009 S.266 - Medicare Prescription Drug Gap Reduction Act of 2009 H.R. ____ - House Tri-Committee Health Reform S.____ Affordable Health Choices Act
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Chronic care out of pocket costs Medicare Prescription Drug Benefit Medicaid drug rebate Medicare and Medicaid Drug Reimbursement Medicaid Rebate Medicaid Part D Non-Interference S.301 Physician Payments Sunshine Act of 2009 S.547/H.R. 904 - Drug Rebate Equalization Act of 2009 H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009 S.266 - Medicare Prescription Drug Gap Reduction Act of 2009
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S. ___ Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care reform legislation FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S.1679 Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Hormone replacement therapies Chronic care out of pocket costs Federal preemption Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to bioidentical hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 Federal preemption for prescription drugs
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S. ___ Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care reform legislation FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S.1679 Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Hormone replacement therapies Chronic care out of pocket costs Federal preemption Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to bioidentical hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 Federal preemption for prescription drugs
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Hormone replacement therapies Chronic care out of pocket costs Federal preemption Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to bioidentical hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 Federal preemption for prescription drugs
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S. ___ Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care reform legislation FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S.1679 Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care reform legislation FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S.1679 Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Hormone replacement therapies Chronic care out of pocket costs Federal preemption Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to bioidentical hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 Federal preemption for prescription drugs
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S. ___ Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
S. 726/H.R. 1427 - Access to Life-Saving Medicine Act, Follow-on Biologics H.R. 1548 - The Pathway for Biosimilars Act Biosimilars Drug Safety Prescription Drug Importation Import Safety Compounding H.R. 759 - Food and Drug Administration Globaliation Act of 2009 S. 510 - FDA Food Safety Modernization Act
FDA reform proposals; Pseudoephedrine H.R. 1259 DXM Distribution Act Monograph System Reform Proposal Pseudoephedrine Electronic Log Proposal S.1383 Dextromethorphan Abuse Reduction Act of 2009 H.R. 2749 Food Safety Enhancement Act of 2009 S. 510 Food Safety Modernization Act of 2009
S. 726/H.R. 1427 - Access to Life-Saving Medicine Act, Follow-on Biologics H.R. 1548 - The Pathway for Biosimilars Act Biosimilars Drug Safety Prescription Drug Importation Import Safety Compounding H.R. 759 - Food and Drug Administration Globaliation Act of 2009 S. 510 - FDA Food Safety Modernization Act
S. 726/H.R. 1427 - Access to Life-Saving Medicine Act, Follow-on Biologics H.R. 1548 - The Pathway for Biosimilars Act Biosimilars Drug Safety Prescription Drug Importation Import Safety Compounding H.R. 759 - Food and Drug Administration Globaliation Act of 2009 S. 510 - FDA Food Safety Modernization Act
FDA reform proposals; Pseudoephedrine H.R. 1259 DXM Distribution Act Monograph System Reform Proposal Pseudoephedrine Electronic Log Proposal S.1383 Dextromethorphan Abuse Reduction Act of 2009 H.R. 2749 Food Safety Enhancement Act of 2009 S. 510 Food Safety Modernization Act of 2009
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Hormone replacement therapies Chronic care out of pocket costs Federal preemption Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to bioidentical hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 Federal preemption for prescription drugs
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S. ___ Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care reform legislation FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S.1679 Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Chronic care out of pocket costs Medicare Prescription Drug Benefit Medicaid drug rebate Medicare and Medicaid Drug Reimbursement Medicaid Part D Non-Interference S.301/HR 3138 Physician Payments Sunshine Act of 2009 S.547/H.R. 904 - Drug Rebate Equalization Act of 2009 H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009 S.266 - Medicare Prescription Drug Gap Reduction Act of 2009 S.1679 Affordable Health Choices Act
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Chronic care out of pocket costs Medicare Prescription Drug Benefit Medicaid drug rebate Medicare and Medicaid Drug Reimbursement Medicaid Part D Non-Interference S.301 Physician Payments Sunshine Act of 2009 S.547/H.R. 904 - Drug Rebate Equalization Act of 2009 H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009 S.266 - Medicare Prescription Drug Gap Reduction Act of 2009 H.R. ____ - House Tri-Committee Health Reform S.____ Affordable Health Choices Act
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Chronic care out of pocket costs Medicare Prescription Drug Benefit Medicaid drug rebate Medicare and Medicaid Drug Reimbursement Medicaid Rebate Medicaid Part D Non-Interference S.301 Physician Payments Sunshine Act of 2009 S.547/H.R. 904 - Drug Rebate Equalization Act of 2009 H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009 S.266 - Medicare Prescription Drug Gap Reduction Act of 2009
S. 726/H.R. 1427 - Access to Life-Saving Medicine Act, Follow-on Biologics H.R. 1548 - The Pathway for Biosimilars Act Biosimilars Drug Safety Prescription Drug Importation Import Safety Compounding H.R. 759 - Food and Drug Administration Globaliation Act of 2009 S. 510 - FDA Food Safety Modernization Act
S. 726/H.R. 1427 - Access to Life-Saving Medicine Act, Follow-on Biologics H.R. 1548 - The Pathway for Biosimilars Act Biosimilars Drug Safety Prescription Drug Importation Import Safety Compounding H.R. 759 - Food and Drug Administration Globaliation Act of 2009 S. 510 - FDA Food Safety Modernization Act
S. 726/H.R. 1427 - Access to Life-Saving Medicine Act, Follow-on Biologics H.R. 1548 - The Pathway for Biosimilars Act Biosimilars Drug Safety Prescription Drug Importation Import Safety Compounding H.R. 759 - Food and Drug Administration Globaliation Act of 2009 S. 510 - FDA Food Safety Modernization Act
Revising the congressional budget for the United States Government for fiscal year 2008, establishing the congressional budget for the United States Government for fiscal year 2009, and setting forth appropriate budgetary levels for fiscal years 2010 through 2013.
Pharmaceutical drug importation; Labor HHS Appropriations; Medicare and Medicaid Drug Reimbursement S.Con.Res 70/H.Con.Res 312 - FY 2009 Budget Resolution H.Res. 1190/S.Con.Res.70/H.Con.Res. 312 - FY 2009 Budget Resolution
Revising the congressional budget for the United States Government for fiscal year 2008, establishing the congressional budget for the United States Government for fiscal year 2009, and setting forth appropriate budgetary levels for fiscal years 2010 through 2013.
Pharmaceutical drug importation; Labor HHS Appropriations; Medicare and Medicaid Drug Reimbursement S.Con.Res 70/H.Con.Res 312 - FY 2009 Budget Resolution
Revising the congressional budget for the United States Government for fiscal year 2008, establishing the congressional budget for the United States Government for fiscal year 2009, and setting forth appropriate budgetary levels for fiscal years 2010 through 2013.
Pharmaceutical drug importation; Labor HHS Appropriations; Medicare and Medicaid Drug Reimbursement S.Con.Res 70/H.Con.Res 312 - FY 2009 Budget Resolution H.Res. 1190/S.Con.Res.70/H.Con.Res. 312 - FY 2009 Budget Resolution
Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.
Vaccine Injury Compensation Program Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; HR 3610 HR 5629 Childhood immunizations Dietary supplement issues FDA reform issues Implementation issues concerning P.L. 108-173 - The Medicare Prescription Drug, Improvement and Modernization Act of 2003 Drug compounding Drug advertising Alzheimer's care Comparative effectiveness S. 1695 Biologics Price Competition and Innovation Act of 2007 H.R. 3043 - Labor/HHS Appropriations Act of 2008 H.R. 1812 - Menopausal Hormone Replacement Therapies and Alternative Treatments and Fairness Act Pediatric Studies and Trials Drug Safety/Clinical Trials H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 S. 623/HR 1038 - Access to Life Saving Medicine Act, Follow-on Biologics S. 1505 - Affordable Biologics for Consumers Act H.R. 3610 - Food and Drug Import Safety Act of 2007 S.2029 - Vaccine Safety and Payment Health care issues Drug approvals Reimbursement rates S. 334 The Healthy Americans Act H.Con.Res. 342 (BHRT) FDA Pre-emption
Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.
Vaccine Injury Compensation Program Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; HR 3610 HR 5629 Childhood immunizations Dietary supplement issues Implementation issues concerning P.L. 108-173 - The Medicare Prescription Drug, Improvement and Modernization Act of 2003 Drug compounding Alzheimer's care Comparative effectiveness - S.3408 - Comparative Effectiveness Research Act of 2008 S. 1695 Biologics Price Competition and Innovation Act of 2007 H.R. 1812 - Menopausal Hormone Replacement Therapies and Alternative Treatments and Fairness Act Pediatric Studies and Trials Drug Safety/Clinical Trials H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 S. 623/HR 1038 - Access to Life Saving Medicine Act, Follow-on Biologics S. 1505 - Affordable Biologics for Consumers Act H.R. 3610 - Food and Drug Import Safety Act of 2007 S.2029 - Vaccine Safety and Payment Health care issues Drug approvals Reimbursement rates S. 334 The Healthy Americans Act H.Con.Res. 342 (BHRT) FDA Pre-emption S.3613, H.R. 7114 - Independence at Home Act S.3409-Drug and Device Accountability Act of 2008 Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Hormone replacement therapies
Expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.
Vaccine Injury Compensation Program Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; HR 3610 HR 5629 Childhood immunizations Dietary supplement issues Implementation issues concerning P.L. 108-173 - The Medicare Prescription Drug, Improvement and Modernization Act of 2003 Drug compounding Alzheimer's care Comparative effectiveness - S.3408 - Comparative Effectiveness Research Act of 2008 S. 1695 Biologics Price Competition and Innovation Act of 2007 H.R. 1812 - Menopausal Hormone Replacement Therapies and Alternative Treatments and Fairness Act Pediatric Studies and Trials Drug Safety/Clinical Trials H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 S. 623/HR 1038 - Access to Life Saving Medicine Act, Follow-on Biologics S. 1505 - Affordable Biologics for Consumers Act H.R. 3610 - Food and Drug Import Safety Act of 2007 S.2029 - Vaccine Safety and Payment Health care issues Drug approvals Reimbursement rates S. 334 The Healthy Americans Act H.Con.Res. 342 (BHRT) FDA Pre-emption S.3613, H.R. 7114 - Independence at Home Act S.3409-Drug and Device Accountability Act of 2008 Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Hormone replacement therapies Chronic Illness International public health issues International vaccine issues
Vaccine Injury Compensation Program Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; HR 3610 HR 5629 Childhood immunizations Dietary supplement issues FDA reform issues Implementation issues concerning P.L. 108-173 - The Medicare Prescription Drug, Improvement and Modernization Act of 2003 Drug compounding Drug advertising Alzheimer's care Comparative effectiveness S. 1695 Biologics Price Competition and Innovation Act of 2007 H.R. 3043 - Labor/HHS Appropriations Act of 2008 H.R. 1812 - Menopausal Hormone Replacement Therapies and Alternative Treatments and Fairness Act Pediatric Studies and Trials Drug Safety/Clinical Trials H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 S. 623/HR 1038 - Access to Life Saving Medicine Act, Follow-on Biologics S. 1505 - Affordable Biologics for Consumers Act H.R. 3610 - Food and Drug Import Safety Act of 2007 S.2029 - Vaccine Safety and Payment Health care issues Drug approvals Reimbursement rates S. 334 The Healthy Americans Act H.Con.Res. 342 (BHRT) FDA Pre-emption
Vaccine Injury Compensation Program Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; HR 3610 HR 5629 Childhood immunizations Dietary supplement issues Implementation issues concerning P.L. 108-173 - The Medicare Prescription Drug, Improvement and Modernization Act of 2003 Drug compounding Alzheimer's care Comparative effectiveness - S.3408 - Comparative Effectiveness Research Act of 2008 S. 1695 Biologics Price Competition and Innovation Act of 2007 H.R. 1812 - Menopausal Hormone Replacement Therapies and Alternative Treatments and Fairness Act Pediatric Studies and Trials Drug Safety/Clinical Trials H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 S. 623/HR 1038 - Access to Life Saving Medicine Act, Follow-on Biologics S. 1505 - Affordable Biologics for Consumers Act H.R. 3610 - Food and Drug Import Safety Act of 2007 S.2029 - Vaccine Safety and Payment Health care issues Drug approvals Reimbursement rates S. 334 The Healthy Americans Act H.Con.Res. 342 (BHRT) FDA Pre-emption S.3613, H.R. 7114 - Independence at Home Act S.3409-Drug and Device Accountability Act of 2008 Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Hormone replacement therapies Chronic Illness International public health issues International vaccine issues
Vaccine Injury Compensation Program Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; HR 3610 HR 5629 Childhood immunizations Dietary supplement issues Implementation issues concerning P.L. 108-173 - The Medicare Prescription Drug, Improvement and Modernization Act of 2003 Drug compounding Alzheimer's care Comparative effectiveness - S.3408 - Comparative Effectiveness Research Act of 2008 S. 1695 Biologics Price Competition and Innovation Act of 2007 H.R. 1812 - Menopausal Hormone Replacement Therapies and Alternative Treatments and Fairness Act Pediatric Studies and Trials Drug Safety/Clinical Trials H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 S. 623/HR 1038 - Access to Life Saving Medicine Act, Follow-on Biologics S. 1505 - Affordable Biologics for Consumers Act H.R. 3610 - Food and Drug Import Safety Act of 2007 S.2029 - Vaccine Safety and Payment Health care issues Drug approvals Reimbursement rates S. 334 The Healthy Americans Act H.Con.Res. 342 (BHRT) FDA Pre-emption S.3613, H.R. 7114 - Independence at Home Act S.3409-Drug and Device Accountability Act of 2008 Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Hormone replacement therapies
H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 S. 623/HR 1038 - Access to Life-Saving Medicine Act, Follow-on Biologics S.1695 - Biologics Price Competition and Innovation Act of 2007 S.1505- Affordable Biologics for Consumers Act H.R. 5629 - "Pathway for Biosimilars Act" H.R. 3610 - Food and Drug Import Safety Act of 2007 S.3409 - Drug and Device Accountability Act of 2008
Vaccine Injury Compensation Program Follow developments within the Bush Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies HR 3610 HR 5629 Issues relating to support of Office of Women's Health and Public Education Initiatives Childhood immunizations Dietary supplement issues FDA reform issues Implementation issues concerning P.L. 108-173 - The Medicare Prescription Drug, Improvement and Modernization Act of 2003 Drug compounding Drug advertising Alzheimer's care Comparative effectiveness S. 1695 Biologics Price Competition and Innovation Act of 2007 Issues related to hormone therapy H.R. 3043 - Labor/HHS Appropriations Act of 2008 S. 1276 - Methamphetamine Production Prevention Act of 2007 H.R. 1812 - Menopausal Hormone Replacement Therapies and Alternative Treatments and Fairness Act Pediatric Studies and Trials Follow-on biologics Drug importation and counterfeiting Drug Safety/Clinical Trials H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 S. 623/HR 1038 - Access to Life Saving Medicine Act, Follow-on Biologics S. 1505 - Affordable Biologics for Consumers Act H.R. 3610 - Food and Drug Import Safety Act of 2007 S.2029 - Vaccine Safety and Payment Health care issues Drug approvals Reimbursement rates
H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 S. 623/HR 1038 - Access to Life-Saving Medicine Act, Follow-on Biologics S.1695 - Biologics Price Competition and Innovation Act of 2007 S1505- Affordable Biologics for Consumers Act H.R. 5629 - "Pathway for Biosimilars Act" H.R. 3610 - Food and Drug Import Safety Act of 2007
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care reform legislation FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S.1679 Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
FDA reform proposals; Pseudoephedrine H.R. 1259 DXM Distribution Act Monograph System Reform Proposal Pseudoephedrine Electronic Log Proposal S.1383 Dextromethorphan Abuse Reduction Act of 2009 H.R. 2749 Food Safety Enhancement Act of 2009 S. 510 Food Safety Modernization Act of 2009
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Security Agency (NSA), Natl Security Council (NSC), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
S. 726/H.R. 1427 - Access to Life-Saving Medicine Act, Follow-on Biologics H.R. 1548 - The Pathway for Biosimilars Act Biosimilars Drug Safety Prescription Drug Importation Import Safety Compounding H.R. 759 - Food and Drug Administration Globaliation Act of 2009 S. 510 - FDA Food Safety Modernization Act
FDA reform proposals; Pseudoephedrine H.R. 1259 DXM Distribution Act Monograph System Reform Proposal Pseudoephedrine Electronic Log Proposal S.1383 Dextromethorphan Abuse Reduction Act of 2009 H.R. 2749 Food Safety Enhancement Act of 2009 S. 510 Food Safety Modernization Act of 2009
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S. ___ Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Chronic care out of pocket costs Medicare Prescription Drug Benefit Medicaid drug rebate Medicare and Medicaid Drug Reimbursement Medicaid Part D Non-Interference S.301 Physician Payments Sunshine Act of 2009 S.547/H.R. 904 - Drug Rebate Equalization Act of 2009 H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009 S.266 - Medicare Prescription Drug Gap Reduction Act of 2009 H.R. ____ - House Tri-Committee Health Reform S.____ Affordable Health Choices Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Security Agency (NSA), Natl Security Council (NSC), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Hormone replacement therapies Chronic care out of pocket costs Federal preemption Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to bioidentical hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 Federal preemption for prescription drugs
S. 726/H.R. 1427 - Access to Life-Saving Medicine Act, Follow-on Biologics H.R. 1548 - The Pathway for Biosimilars Act Biosimilars Drug Safety Prescription Drug Importation Import Safety Compounding H.R. 759 - Food and Drug Administration Globaliation Act of 2009 S. 510 - FDA Food Safety Modernization Act
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Chronic care out of pocket costs Medicare Prescription Drug Benefit Medicaid drug rebate Medicare and Medicaid Drug Reimbursement Medicaid Rebate Medicaid Part D Non-Interference S.301 Physician Payments Sunshine Act of 2009 S.547/H.R. 904 - Drug Rebate Equalization Act of 2009 H.R. 1725 - Voluntary State Discount Prescription Drug Plan Act of 2009 S.330/H.R. 684 - Medicare Prescription Drug Savings and Choice Act of 2009 S.266 - Medicare Prescription Drug Gap Reduction Act of 2009
FDA reform proposals; Pseudoephedrine H.R. 1259 DXM Distribution Act Monograph System Reform Proposal Pseudoephedrine Electronic Log Proposal
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Security Agency (NSA), Natl Security Council (NSC), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
FDA reform proposals; Pseudoephedrine H.R. 970 DXM Distribution Act S. 1378 DXM Distribution Act S. 2274 Dextromethorphan Abuse Reduction Act Monograph System Reform Proposal S. 2274 DXM Abuse Reduction Act
Vaccine Injury Compensation Program Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; HR 3610 HR 5629 Childhood immunizations Dietary supplement issues Implementation issues concerning P.L. 108-173 - The Medicare Prescription Drug, Improvement and Modernization Act of 2003 Drug compounding Alzheimer's care Comparative effectiveness - S.3408 - Comparative Effectiveness Research Act of 2008 S. 1695 Biologics Price Competition and Innovation Act of 2007 H.R. 1812 - Menopausal Hormone Replacement Therapies and Alternative Treatments and Fairness Act Pediatric Studies and Trials Drug Safety/Clinical Trials H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 S. 623/HR 1038 - Access to Life Saving Medicine Act, Follow-on Biologics S. 1505 - Affordable Biologics for Consumers Act H.R. 3610 - Food and Drug Import Safety Act of 2007 S.2029 - Vaccine Safety and Payment Health care issues Drug approvals Reimbursement rates S. 334 The Healthy Americans Act H.Con.Res. 342 (BHRT) FDA Pre-emption S.3613, H.R. 7114 - Independence at Home Act S.3409-Drug and Device Accountability Act of 2008 Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Hormone replacement therapies Chronic Illness International public health issues International vaccine issues
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Issues relating to Medicaid reimbursement for drugs/biologics in Title VI of S.1932-the Deficit Reduction Act of 2005 Pediatric Exclusivity H.R. 4 - Medicare Prescription Drug Price Negotiation Act H.R. 3162 - Children's Health and Medicare Protection Act of 2007 S.1893/H.R. 976 - Children's Health Insurance Progam Reauthorization Act of 2007 S. 2499 - Medicare, Medicaid and SCHIP Extension Act of 2007 Chronic care out of pocket costs S. 2029 - Physician Payments Sunshine Act of 2007 HR 5605 - Physician Payments Sunshine Act of 2007 HR 2185 - Enhanced Healthcare Value for All Act Medicare Prescription Drug Benefit Medicaid drug rebate Medicare Physician Reimbursement package Medicare and Medicaid Drug Reimbursement Medicaid Rebate Medicaid Part D Non-Interference H.R. 6331/S.3101 - Medicare Improvements for Patients and Providers Act of 2008 S.3118 - Preserving Access to Medicare Act of 2008 S.3613, H.R. 7114 - Independence at Home Act
Taxation of International Operations of U.S. corporations generally; Homeland investment legislation; R&D tax credit; H.R. 1424 and H.R. 7060;
H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 S. 623/HR 1038 - Access to Life-Saving Medicine Act, Follow-on Biologics S.1695 - Biologics Price Competition and Innovation Act of 2007 S.1505- Affordable Biologics for Consumers Act H.R. 5629 - "Pathway for Biosimilars Act" H.R. 3610 - Food and Drug Import Safety Act of 2007 S.3409 - Drug and Device Accountability Act of 2008 Biosimilars Drug Safety Prescription Drug Importation Import Safety Compoundin
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Security Agency (NSA), Natl Security Council (NSC), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Taxation of International Operations of U.S. corporations generally R&D tax credit Taxation of Deferred Compensation Plans Foreign tax credit legislation; Homeland investment legislation
H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 S. 623/HR 1038 - Access to Life-Saving Medicine Act, Follow-on Biologics S.1695 - Biologics Price Competition and Innovation Act of 2007 S.1505- Affordable Biologics for Consumers Act H.R. 5629 - "Pathway for Biosimilars Act" H.R. 3610 - Food and Drug Import Safety Act of 2007 S.3409 - Drug and Device Accountability Act of 2008
Vaccine Injury Compensation Program Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; HR 3610 HR 5629 Childhood immunizations Dietary supplement issues Implementation issues concerning P.L. 108-173 - The Medicare Prescription Drug, Improvement and Modernization Act of 2003 Drug compounding Alzheimer's care Comparative effectiveness - S.3408 - Comparative Effectiveness Research Act of 2008 S. 1695 Biologics Price Competition and Innovation Act of 2007 H.R. 1812 - Menopausal Hormone Replacement Therapies and Alternative Treatments and Fairness Act Pediatric Studies and Trials Drug Safety/Clinical Trials H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 S. 623/HR 1038 - Access to Life Saving Medicine Act, Follow-on Biologics S. 1505 - Affordable Biologics for Consumers Act H.R. 3610 - Food and Drug Import Safety Act of 2007 S.2029 - Vaccine Safety and Payment Health care issues Drug approvals Reimbursement rates S. 334 The Healthy Americans Act H.Con.Res. 342 (BHRT) FDA Pre-emption S.3613, H.R. 7114 - Independence at Home Act S.3409-Drug and Device Accountability Act of 2008 Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Hormone replacement therapies
FDA reform proposals; Pseudoephedrine H.R. 970 DXM Distribution Act S. 1378 DXM Distribution Act S. 2274 Dextromethorphan Abuse Reduction Act Monograph System Reform Proposal S. 2274 DXM Abuse Reduction Act
Vaccines Medicare chronic disease coverage Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Issues relating to Medicaid reimbursement for drugs/biologics in Title VI of S.1932-the Deficit Reduction Act of 2005 Pediatric Exclusivity H.R. 4 - Medicare Prescription Drug Price Negotiation Act H.R. 3162 - Children's Health and Medicare Protection Act of 2007 S.1893/H.R. 976 - Children's Health Insurance Progam Reauthorization Act of 2007 S. 2499 - Medicare, Medicaid and SCHIP Extension Act of 2007 Chronic care out of pocket costs S. 2029 - Physician Payments Sunshine Act of 2007 HR 5605 - Physician Payments Sunshine Act of 2007 HR 2185 - Enhanced Healthcare Value for All Act Medicare Prescription Drug Benefit Medicaid drug rebate Medicare Physician Reimbursement package Medicare and Medicaid Drug Reimbursement Medicaid Rebate Medicaid Part D Non-Interference H.R. 6331/S.3101 - Medicare Improvements for Patients and Providers Act of 2008 S.3118 - Preserving Access to Medicare Act of 2008 S.3613, H.R. 7114 - Independence at Home Act
Pharmaceutical drug importation; Labor HHS Appropriations; Medicare and Medicaid Drug Reimbursement S.Con.Res 70/H.Con.Res 312 - FY 2009 Budget Resolution H.Res. 1190/S.Con.Res.70/H.Con.Res. 312 - FY 2009 Budget Resolution
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Security Agency (NSA), Natl Security Council (NSC), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
FDA reform proposals; Pseudoephedrine H.R. 970 DXM Distribution Act S. 1378 DXM Distribution Act S. 2274 Dextromethorpha Abuse Reduction Act Monograph System Reform Proposal S. 2274 DXM Abuse Reduction Act
H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 S. 623/HR 1038 - Access to Life-Saving Medicine Act, Follow-on Biologics S.1695 - Biologics Price Competition and Innovation Act of 2007 S1505- Affordable Biologics for Consumers Act H.R. 5629 - "Pathway for Biosimilars Act" H.R. 3610 - Food and Drug Import Safety Act of 2007
Taxation of International Operations of U.S. corporations generally R&D tax credit Taxation of Deferred Compensation Plans Foreign tax credit legislation; Homeland investment legislation
FDA reform proposals; Pseudoephedrine S. 1276 Methamphetamine Production Preventation Act of 2007 H.R. 970 DXM Distribution Act S. 1378 DXM Distribution Act DXM Abuse Monograph System Reform Proposal S. 2274 DXM Abuse Reduction Act H.R. 4083 Non-Prescription Drug modernization Act of 2007
Vaccine Injury Compensation Program Follow developments within the Bush Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies HR 3610 HR 5629 Issues relating to support of Office of Women's Health and Public Education Initiatives Childhood immunizations Dietary supplement issues FDA reform issues Implementation issues concerning P.L. 108-173 - The Medicare Prescription Drug, Improvement and Modernization Act of 2003 Drug compounding Drug advertising Alzheimer's care Comparative effectiveness S. 1695 Biologics Price Competition and Innovation Act of 2007 Issues related to hormone therapy H.R. 3043 - Labor/HHS Appropriations Act of 2008 S. 1276 - Methamphetamine Production Prevention Act of 2007 H.R. 1812 - Menopausal Hormone Replacement Therapies and Alternative Treatments and Fairness Act Pediatric Studies and Trials Follow-on biologics Drug importation and counterfeiting Drug Safety/Clinical Trials H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 S. 623/HR 1038 - Access to Life Saving Medicine Act, Follow-on Biologics S. 1505 - Affordable Biologics for Consumers Act H.R. 3610 - Food and Drug Import Safety Act of 2007 S.2029 - Vaccine Safety and Payment Health care issues Drug approvals Reimbursement rates
Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Issues relating to Medicaid reimbursement for drugs/biologics in Title VI of S.1932-the Deficit Reduction Act of 2005 Pediatric Exclusivity H.R. 4 Medicare Prescription Drug Prie Negoation Act Prescription drug user fees; Methamphetamines Vaccines
Monitor U.S. trade policies relating to intellectual property protection under the WTO TRIPS agreement H.R. 1908 Patent Reform Act of 2007 S. 1145 Patent Reform Act of 2007
Issues relating to support of Office of Women's Health and Public Education Initiatives Childhood immunizations Dietary supplement issues FDA reform issues Medicare reimbursement for certain drugs Importation Implementation issues concerning P.L. 108-173 - The Medicare Prescription Drug, Improvement and Modernization Act of 2003 Follow developments within the Bush Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies Drug Compounding Alzheimer's care H.R. 2900 Food and Drug Administration Act of 2007 S.1695 Biologics Price Compeition and Innovation Act of 2007 Issues related to hormone therapy H.R. 3043 Labor/HHS Appropriations Act of 2008 S. 1276 Methamphetamine Production Prevention Act of 2007 S.1082 FDA Revitalization Act of 2007 H.R. 1812 Menopausal Hormone Replacement Therapies and Alternative Treatments and Fairness Act Pediatric Studies and Trials Follow-on Biologics Drug Importation and Counterfeiting Prescription Drug User Fees Drug Safety/Clinical Trials Vaccine Injury Compensation Program Follow developments within the Bush Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies
S.109/H.R. 328 - Pharmaceutical Market Access Act Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Issues concerning Medicaid in the Concurrent Resolution on the Budget - Fiscal Year 2006 Medicare coverage of pharmaceuticals, Medicare Part D Issues relating to Medicaid reimbursement for drugs/biologics in Title VI of S.1932-the Deficit Reduction Act of 2005 Pediatric Exclusivity Prescription drug user fees; Methamphetamines Vaccines Non-Interference H.R. 4939, Supplemental Appropriations H.R. 6111 - Tax Relief and Health Care Act of 2006 Pharmaceutical reimbursement rates Medicare reform; Vaccines; Importation; Bioterrorism; Direct to consumer advertising S.975-Project Bioshield II Acts
Monitor U.S. trade policies relating to intellectual property protection under the WTO TRIPS agreement H.R. 5418 H.R. 2795
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Security Council (NSC), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), Vice President of the U.S.
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Security Council (NSC), Office of the Vice President of the United States, SENATE, Securities & Exchange Commission (SEC), State, Dept of (DOS), U.S. Trade Representative (USTR)
Methamphetamines Vaccines Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Issues relating to Medicaid reimbursement for drugs/biologics in Title VI of S.1932-the Deficit Reduction Act of 2005 Pediatric Exclusivity H.R. 4 - Medicare Prescription Drug Price Negotiation Act H.R. 3162 - Children's Health and Medicare Protection Act of 2007 S.1893/H.R. 976 - Children's Health Insurance Progam Reauthorization Act of 2007 S. 2499 - Medicare, Medicaid and SCHIP Extension Act of 2007 Chronic care out of pocket costs S. 2029 - Physician Payments Sunshine Act of 2007 HR 5605 - Physician Payments Sunshine Act of 2007 HR 2185 - Enhanced Healthcare Value for All Act Medicare Prescription Drug Benefit Medicaid drug rebate Medicare Physician Reimbursement package Medicare and Medicaid Drug Reimbursement Medicaid Rebate Medicaid Part D Non-Interference H.R. 6331/S.3101 - Medicare Improvements for Patients and Providers Act of 2008 S.3118 - Preserving Access to Medicare Act of 2008
Vaccine Injury Compensation Program Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; HR 3610 HR 5629 Childhood immunizations Dietary supplement issues FDA reform issues Implementation issues concerning P.L. 108-173 - The Medicare Prescription Drug, Improvement and Modernization Act of 2003 Drug compounding Drug advertising Alzheimer's care Comparative effectiveness S. 1695 Biologics Price Competition and Innovation Act of 2007 H.R. 3043 - Labor/HHS Appropriations Act of 2008 H.R. 1812 - Menopausal Hormone Replacement Therapies and Alternative Treatments and Fairness Act Pediatric Studies and Trials Drug Safety/Clinical Trials H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 S. 623/HR 1038 - Access to Life Saving Medicine Act, Follow-on Biologics S. 1505 - Affordable Biologics for Consumers Act H.R. 3610 - Food and Drug Import Safety Act of 2007 S.2029 - Vaccine Safety and Payment Health care issues Drug approvals Reimbursement rates S. 334 The Healthy Americans Act H.Con.Res. 342 (BHRT) FDA Pre-emption
Pharmaceutical drug importation; Labor HHS Appropriations; Medicare and Medicaid Drug Reimbursement S.Con.Res 70/H.Con.Res 312 - FY 2009 Budget Resolution H.Res. 1190/S.Con.Res.70/H.Con.Res. 312 - FY 2009 Budget Resolution
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Security Agency (NSA), Natl Security Council (NSC), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Pharmaceutical drug importation; Labor HHS Appropriations; Medicare and Medicaid Drug Reimbursement S.Con.Res 70/H.Con.Res 312 - FY 2009 Budget Resolution
Methamphetamines Vaccines Implementation Issues concerning P.L. 108-173 - the Medicare Prescription Drug, Improvement and Modernization Act of 2003 Medicare coverage of pharmaceuticals, Medicare Part D Issues relating to Medicaid reimbursement for drugs/biologics in Title VI of S.1932-the Deficit Reduction Act of 2005 Pediatric Exclusivity H.R. 4 - Medicare Prescription Drug Price Negotiation Act H.R. 3162 - Children's Health and Medicare Protection Act of 2007 S.1893/H.R. 976 - Children's Health Insurance Progam Reauthorization Act of 2007 S. 2499 - Medicare, Medicaid and SCHIP Extension Act of 2007 Chronic care out of pocket costs S. 2029 - Physician Payments Sunshine Act of 2007 HR 5605 - Physician Payments Sunshine Act of 2007 HR 2185 - Enhanced Healthcare Value for All Act Medicare Physician Reimbursement package Medicare and Medicaid Drug Reimbursement Medicaid Rebate Medicaid Part D Non-Interference
H.R. 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007 S. 623/HR 1038 - Access to Life-Saving Medicine Act, Follow-on Biologics S.1695 - Biologics Price Competition and Innovation Act of 2007 S1505- Affordable Biologics for Consumers Act H.R. 5629 - "Pathway for Biosimilars Act" H.R. 3610 - Food and Drug Import Safety Act of 2007 Biosimilars Drug Safety Prescription Drug Importation Import Safety
Taxation of International Operations of U.S. corporations generally R&D tax credit Taxation of Deferred Compensation Plans Foreign tax credit legislation; Homeland investment legislation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Security Agency (NSA), Natl Security Council (NSC), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Pharmaceutical drug importation S. Con Res 21 FY 2008 Senate Budget Resolution
S. 1276 Methamphetamine Production Prevention Act of 2007 H.R. 970 DXM Distribution Act S.1378 DXM Distribution Act FDA reform proposals; Pseudoephedrine;
Monitor U.S. trade policies relating to intellectual property protection under the WTO TRIPS agreement Importation of FDA-approved pharmaceuticals
Puerto Rico Tax Incentives; Taxation of International Operations of U.S. corporations generally R&D Tax Credit; Taxation of Deferred Compensation Plans; Homeland Investment legislation
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Security Council (NSC), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office
Tort and product liability reform; Medical malpractice reform FDA reform proposals; Pseudoephedrine; H.R. 5280 - Dextromethorphan
Tort and product liability reform Medical malpractice reform; FDA reform proposals
Monitor U.S. trade policies relating to intellectual property protection under the WTO TRIPS agreement Importation of FDA-approved pharmaceuticals
Puerto Rico Tax Incentives; Taxation of International Operations of U.S. corporations generally R&D Tax Credit; H.R. 6111
Issues relating to support of Office of Women's Health and Public Education Initiatives Childhood immunizations Dietary supplement issues FDA reform issues S.3 Protecting America in the War on Terror H.R. 650 Vaccines Act of 2005 H.R. 2863 Department of Defense Appropriations Act of 2006 Medicare reimbursement for certain drugs Importation Bioterrorism Direct to consumer advertising S.334 Pharmaceutical Market Access and Drug Safety Act of 2005 Implementation issues concerning P.L. 108-173 - The Medicare Prescription Drug, Improvement and Modernization Act of 2003 Issues concerning Medicaid in the Concurrent Resolution on the Budget - Fiscal Year 2006 Medical coverage of self-injective biologicals Issues related to vaccine injury compensation program Follow developments within the Bush Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies Issues relating to Medicaid reimbursement for drugs/biologics in Title VI of S.1932-the Deficit Reduction Act of 2005 Pandemic Influenza S.3678 S. Con. Res 83, "Concurrent Resolution on the Budget for Fiscal Year 2007,: issues relating to amending the Medicare Prescription Drug and Modernization Act of 2003 (P.L.108-173) to authorize the Secretary of HHS to negotiate drug prices for the Part D Medicare prescription drug benefit. H.R. 5384, "Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act of 2007," issues related to the importation of prescription drugs. Issues related to vaccine injury compensation program S.843 - The Combating Autism Act of 2005 H.R. 4939 - Supplemental Appropriations H.R. 5441 - FY 2007 Homeland Security Appropriations Drug Compounding H.R. 5122, S.2767 - Department of Defense Authorizations S.3807 - Enhancing Drug Safety and Innovation Act of 2006 Alzheimer's care HR 5211; S.2767 - Department of Defense Authorizations H.R. 5384 - "Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act of 2007," issues related to the importation of prescription drugs; issues related to the Vaccine Injury Compensation Program Issues related to hormone therapy and the use of HT and BHRT products. Vaccine Injury Compensation Program Follow developments within the Bush Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies
Pharmaceutical drug importation H.R. 5384 - Agriculture and Related Agencies Appropriation/Food and Drug Administration HJ Res.102 - Continuing Appropriations Resolutions
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Natl Security Council (NSC), Office of the Vice President of the United States, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office